MHRA Class 3 Medicines Recall: Ramipril 1.25mg tablets (Torrent Pharma (UK) Limited)

Drug alert number: EL (24)A/05

Date issued: 12 February 2024

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Ramipril 1.25mg tablets (Torrent Pharma (UK) Limited) PL 36687/0222

SNOMED Code: 36834211000001109

Active Pharmaceutical Ingredient: Ramipril

Brief description of the problem

Torrent Pharma (UK) Limited is recalling the above batches of Ramipril 1.25mg tablets as a precautionary measure due to these batches having a low assay and high related substances test results after their release to the market.

Advice for healthcare professionals

Stop supplying the above batches immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

Full drug alert can be viewed here.

Advice for patients

No further action is required by patients, these batches are being recalled at the pharmacy and wholesaler level as a precautionary measure. Patients who experience adverse reactions or have any questions about the medication, should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme.

Further Information

For medical information enquiries please contact APCER Life Sciences, via telephone: 0800 0885366, or email: Medinfo.Torrent@apcerls.com

For stock control enquiries please contact the Torrent Pharma (UK) Limited Customer Service & Sales Executive via telephone: 01293 574188,or email:  luke.davies@torrentpharma.co.uk  or priti.pragji@torrentpharma.co.uk